{"count": 11, "results": [{"_id": "28624170", "pmid": 28624170, "title": "Predictors of visit-to-visit blood pressure variability in patients with hypertension: an analysis of trials with an amlodipine treatment arm.", "journal": "J Am Soc Hypertens", "authors": ["Wang JG", "Zhou D", "Jeffers BW"], "date": "2017-07-01T00:00:00Z", "doi": "10.1016/j.jash.2017.05.006", "meta_date_publication": "2017 Jul", "meta_volume": "11", "meta_issue": "7", "meta_pages": "402-411", "score": 50052.605, "text_hl": "BPV in the top 25th percentile was lower with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ versus other treatments (13.7 +- 3.2 vs. 14.3 +- 3.5), with single-study analyses of Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm, Antihypertensive and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@Lipid@@@-Lowering Treatment to Prevent @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@Heart Attack@@@ Trial, and Comparison of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ Versus @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@Enalapril@@@ to Limit Occurrences of @<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@Thrombosis@@@ all showing BPV was the lowest with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@. ", "citations": {"NLM": "Wang JG, Zhou D, Jeffers BW. Predictors of visit-to-visit blood pressure variability in patients with hypertension: an analysis of trials with an amlodipine treatment arm. J Am Soc Hypertens. 2017 Jul;11(7):402-411. PMID: 28624170", "BibTeX": "@article{28624170, title={Predictors of visit-to-visit blood pressure variability in patients with hypertension: an analysis of trials with an amlodipine treatment arm.}, author={Wang JG and Zhou D and Jeffers BW}, journal={J Am Soc Hypertens}, volume={11}, number={7}, pages={402-411}}"}}, {"_id": "22520542", "pmid": 22520542, "title": "Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study.", "journal": "Am Heart J", "authors": ["Zamani P", "Ganz P", "Libby P", "Sutradhar SC", "Rifai N", "Nicholls SJ", "Nissen SE", "Kinlay S"], "date": "2012-04-01T00:00:00Z", "doi": "10.1016/j.ahj.2011.12.008", "meta_date_publication": "2012 Apr", "meta_volume": "163", "meta_issue": "4", "meta_pages": "735-40", "score": 50051.91, "text_hl": "We assessed whether 2 commonly used antihypertensive agents affected plasma biomarkers reflecting specific @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ and remodeling processes over 2 years in the Comparison of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ versus @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@Enalapril@@@ to Limit Occurrences of @<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@Thrombosis@@@ (@<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@CAMELOT@@@) study. ", "citations": {"NLM": "Zamani P, Ganz P, Libby P, Sutradhar SC, Rifai N, Nicholls SJ, Nissen SE, Kinlay S. Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study. Am Heart J. 2012 Apr;163(4):735-40. PMID: 22520542", "BibTeX": "@article{22520542, title={Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study.}, author={Zamani P and Ganz P and Libby P and Sutradhar SC and Rifai N and Nicholls SJ and Nissen SE and Kinlay S}, journal={Am Heart J}, volume={163}, number={4}, pages={735-40}}"}}, {"_id": "22735685", "pmid": 22735685, "title": "Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention.", "journal": "Heart", "authors": ["Park KW", "Kang J", "Park JJ", "Yang HM", "Lee HY", "Kang HJ", "Koo BK", "Oh BH", "Park YB", "Kim HS"], "date": "2012-09-01T00:00:00Z", "doi": "10.1136/heartjnl-2012-301892", "meta_date_publication": "2012 Sep", "meta_volume": "98", "meta_issue": "18", "meta_pages": "1366-72", "score": 50050.93, "text_hl": "CONCLUSIONS: Treatment with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ is associated with increased @CHEMICAL_Clopidogrel @CHEMICAL_MESH:D000077144 @@@clopidogrel@@@ OPR and increased risk of @<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@thrombotic@@@ events after PCI, which is dependent on the @GENE_CYP3A5 @GENE_1577 @@@CYP3A5@@@ genetic status.", "citations": {"NLM": "Park KW, Kang J, Park JJ, Yang HM, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS. Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention. Heart. 2012 Sep;98(18):1366-72. PMID: 22735685", "BibTeX": "@article{22735685, title={Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention.}, author={Park KW and Kang J and Park JJ and Yang HM and Lee HY and Kang HJ and Koo BK and Oh BH and Park YB and Kim HS}, journal={Heart}, volume={98}, number={18}, pages={1366-72}}"}}, {"_id": "17161053", "pmid": 17161053, "title": "Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials.", "journal": "Am Heart J", "authors": ["Brener SJ", "Ivanc TB", "Poliszczuk R", "Chen M", "Tuzcu EM", "Hu T", "Frid DJ", "Nissen SE"], "date": "2006-12-01T00:00:00Z", "doi": "10.1016/j.ahj.2006.07.022", "meta_date_publication": "2006 Dec", "meta_volume": "152", "meta_issue": "6", "meta_pages": "1059-63", "score": 50050.9, "text_hl": "Antihypertensive therapy and regression of @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@coronary artery disease@@@: insights from the Comparison of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ versus @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@Enalapril@@@ to Limit Occurrences of @<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@Thrombosis@@@ (CAMELOT) and Norvasc for Regression of Manifest @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@Atherosclerotic Lesions@@@ by Intravascular Sonographic Evaluation (NORMALISE) trials.", "citations": {"NLM": "Brener SJ, Ivanc TB, Poliszczuk R, Chen M, Tuzcu EM, Hu T, Frid DJ, Nissen SE. Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials. Am Heart J. 2006 Dec;152(6):1059-63. PMID: 17161053", "BibTeX": "@article{17161053, title={Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials.}, author={Brener SJ and Ivanc TB and Poliszczuk R and Chen M and Tuzcu EM and Hu T and Frid DJ and Nissen SE}, journal={Am Heart J}, volume={152}, number={6}, pages={1059-63}}"}}, {"_id": "16986228", "pmid": 16986228, "title": "Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trial.", "journal": "J Renin Angiotensin Aldosterone Syst", "authors": ["Ruilope LM", "Zanchetti A"], "date": "2006-06-01T00:00:00Z", "doi": "10.3317/jraas.2006.020", "meta_date_publication": "2006 Jun", "meta_volume": "7 Suppl 1", "meta_issue": "", "meta_pages": "S8-11", "score": 50048.016, "text_hl": "In addition, combination therapy resulted in a trend towards more favourable outcomes with respect to pro-@<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@thrombotic@@@ and proinflammatory markers than @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ alone.", "citations": {"NLM": "Ruilope LM, Zanchetti A. Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trial. J Renin Angiotensin Aldosterone Syst. 2006 Jun;7 Suppl 1():S8-11. PMID: 16986228", "BibTeX": "@article{16986228, title={Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trial.}, author={Ruilope LM and Zanchetti A}, journal={J Renin Angiotensin Aldosterone Syst}, volume={7 Suppl 1}, pages={S8-11}}"}}, {"_id": "15513305", "pmid": 15513305, "title": "Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.", "journal": "Ann Med", "authors": ["Nadar S", "Blann AD", "Lip GY"], "date": "2004-01-01T00:00:00Z", "doi": "10.1080/07853890410017386", "meta_date_publication": "2004", "meta_volume": "36", "meta_issue": "7", "meta_pages": "552-7", "score": 50046.773, "text_hl": "This may contribute to a reduction in @<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@thrombosis@@@-related complications seen in those whose blood pressure lowering is effective.", "citations": {"NLM": "Nadar S, Blann AD, Lip GY. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. Ann Med. 2004;36(7):552-7. PMID: 15513305", "BibTeX": "@article{15513305, title={Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.}, author={Nadar S and Blann AD and Lip GY}, journal={Ann Med}, volume={36}, number={7}, pages={552-7}}"}}, {"_id": "15934908", "pmid": 15934908, "title": "Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved?", "journal": "Expert Opin Pharmacother", "authors": ["Doggrell SA"], "date": "2005-05-01T00:00:00Z", "doi": "10.1517/14656566.6.5.831", "meta_date_publication": "2005 May", "meta_volume": "6", "meta_issue": "5", "meta_pages": "831-4", "score": 50045.5, "text_hl": "Peripheral revascularisation was slightly higher in the @CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@ GITS (187/3825) than the placebo group (144/3840). The Comparison of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ versus @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@Enalapril@@@ to Limit Occurrences of @<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@Thrombosis@@@ (CAMELOT) trial compared a calcium channel blocker (@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@) and angiotensin-converting enzyme inhibitor (@CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@) in normotensive @SPECIES_9606 @@@patients@@@ with @DISEASE_Coronary_Artery_Disease @DISEASE_MESH:D003324 @@@coronary artery disease@@@. ", "citations": {"NLM": "Doggrell SA. Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved? Expert Opin Pharmacother. 2005 May;6(5):831-4. PMID: 15934908", "BibTeX": "@article{15934908, title={Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved?}, author={Doggrell SA}, journal={Expert Opin Pharmacother}, volume={6}, number={5}, pages={831-4}}"}}, {"_id": "30083484", "pmid": 30083484, "pmcid": "PMC6072312", "title": "Fibromuscular Dysplasia Presenting as a Renal Infarct", "journal": "Cureus", "authors": ["Khalid S", "Daw JH", "Nautiyal A", "Daw H"], "date": "2018-03-14T00:00:00Z", "doi": "10.7759/cureus.2326", "meta_date_publication": "2018 Mar 14", "meta_volume": "10", "meta_issue": "3", "meta_pages": "e2326", "score": 50044.414, "text_hl": "The @SPECIES_9606 @@@patient@@@ was started on @CHEMICAL_apixaban @CHEMICAL_MESH:C522181 @@@apixaban@@@ for the @<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@clot@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ for @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Khalid S, Daw JH, Nautiyal A, Daw H. Fibromuscular Dysplasia Presenting as a Renal Infarct Cureus. 2018 Mar 14;10(3):e2326. PMID: 30083484", "BibTeX": "@article{30083484, title={Fibromuscular Dysplasia Presenting as a Renal Infarct}, author={Khalid S and Daw JH and Nautiyal A and Daw H}, journal={Cureus}, volume={10}, number={3}, pages={e2326}}"}}, {"_id": "11798610", "pmid": 11798610, "title": "[Effects of radiofrequency catheter ablation in coagulation system].", "journal": "Zhonghua Nei Ke Za Zhi", "authors": ["Zeng Q", "Qin R", "Zhang G", "Qin C", "Cao L", "Chen Z"], "date": "2001-07-01T00:00:00Z", "meta_date_publication": "2001 Jul", "meta_volume": "40", "meta_issue": "7", "meta_pages": "442-4", "score": 50043.0, "text_hl": "CONCLUSION: It is indicated that platelet aggregability may be introduced by RFCA, but evolution of the anticoagulant system was not caused by RFCA, This may enhance the occurrence of @<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@thrombosis@@@. @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@ASA@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ may prevent the occurrence of @<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@thrombosis@@@.", "citations": {"NLM": "Zeng Q, Qin R, Zhang G, Qin C, Cao L, Chen Z. [Effects of radiofrequency catheter ablation in coagulation system]. Zhonghua Nei Ke Za Zhi. 2001 Jul;40(7):442-4. PMID: 11798610", "BibTeX": "@article{11798610, title={[Effects of radiofrequency catheter ablation in coagulation system].}, author={Zeng Q and Qin R and Zhang G and Qin C and Cao L and Chen Z}, journal={Zhonghua Nei Ke Za Zhi}, volume={40}, number={7}, pages={442-4}}"}}, {"_id": "16904557", "pmid": 16904557, "title": "Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis.", "journal": "J Am Coll Cardiol", "authors": ["Sipahi I", "Tuzcu EM", "Schoenhagen P", "Wolski KE", "Nicholls SJ", "Balog C", "Crowe TD", "Nissen SE"], "date": "2006-08-15T00:00:00Z", "doi": "10.1016/j.jacc.2006.05.045", "meta_date_publication": "2006 Aug 15", "meta_volume": "48", "meta_issue": "4", "meta_pages": "833-8", "score": 50036.555, "text_hl": "METHODS: The 274 @SPECIES_9606 @@@patients@@@ who completed the intravascular ultrasound (IVUS) substudy of the CAMELOT (Comparison of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ Versus @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@Enalapril@@@ to Limit Occurrences of @<m>DISEASE_Thrombosis</m> @DISEASE_MESH:D013927 @@@Thrombosis@@@) trial were included. ", "citations": {"NLM": "Sipahi I, Tuzcu EM, Schoenhagen P, Wolski KE, Nicholls SJ, Balog C, Crowe TD, Nissen SE. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol. 2006 Aug 15;48(4):833-8. PMID: 16904557", "BibTeX": "@article{16904557, title={Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis.}, author={Sipahi I and Tuzcu EM and Schoenhagen P and Wolski KE and Nicholls SJ and Balog C and Crowe TD and Nissen SE}, journal={J Am Coll Cardiol}, volume={48}, number={4}, pages={833-8}}"}}]}